1. Home
  2. OGI vs ADCT Comparison

OGI vs ADCT Comparison

Compare OGI & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Organigram Holdings Inc.

OGI

Organigram Holdings Inc.

N/A

Current Price

$0.88

Market Cap

133.5M

Sector

Health Care

ML Signal

N/A

Logo ADC Therapeutics SA

ADCT

ADC Therapeutics SA

N/A

Current Price

$1.58

Market Cap

136.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OGI
ADCT
Founded
2013
2011
Country
Canada
Switzerland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
133.5M
136.1M
IPO Year
2015
2019

Fundamental Metrics

Financial Performance
Metric
OGI
ADCT
Price
$0.88
$1.58
Analyst Decision
Strong Buy
Buy
Analyst Count
3
5
Target Price
$2.44
★ $3.33
AVG Volume (30 Days)
414.5K
★ 1.6M
Earning Date
12-15-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 30.86
EPS
★ N/A
N/A
Revenue
N/A
★ $81,357,000.00
Revenue This Year
$34.95
N/A
Revenue Next Year
$30.97
$25.32
P/E Ratio
$13.91
★ N/A
Revenue Growth
N/A
★ 14.85
52 Week Low
$0.85
$0.78
52 Week High
$2.24
$4.98

Technical Indicators

Market Signals
Indicator
OGI
ADCT
Relative Strength Index (RSI) 36.55 53.54
Support Level N/A $1.01
Resistance Level $0.96 $1.87
Average True Range (ATR) 0.05 0.14
MACD 0.00 -0.00
Stochastic Oscillator 11.97 32.18

Price Performance

Historical Comparison
OGI
ADCT

About OGI Organigram Holdings Inc.

Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. Additionally, the company's development pipeline comprises LOTIS-2, LOTIS-5, LOTIS-7, and ADCT-241, being developed as potential therapies for different cancer diseases. Geographically, the firm generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

Share on Social Networks: